Applied Molecular Transport (AMTI)
AMTI
GI
BiotechSign Signal Grade
F
Signal Grade
1.2/100 composite signal score
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Insider Buying
0
Publications
100
Clinical Activity
0
Pipeline Overview
- Therapeutic Focus
- GIsrc
Clinical Trial Activity
0
Clinical Trials
(ClinicalTrials.gov aggregate)
(ClinicalTrials.gov aggregate)
5
PubMed Publications
0
Catalyst Records
ClinicalTrials.gov aggregate as of 2026-10-13. ClinicalTrials.gov
Recent News & SEC Filings
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
- SEC 8-K 8-K - Current report
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Polyunsaturated Fatty Acid Supplementation in Multiple Sclerosis Management: A Scoping Review. — Nutrients 2026 Sep 5 PMID 42739087
- Modulatory effects of methyl gallate on the inflammatory response in gout arthritis via P2X7 receptor. — An Acad Bras Cienc 2026 PMID 42690374
- Adolescent health across Asia Pacific, 2000-23: a systematic analysis for the Global Burden of Disease Study 2023. — Lancet Child Adolesc Health 2026 Oct PMID 42679829
- Engineering three-dimensional microvascular tissues with blood vessel openings for drug transport screening assay. — Biochem Biophys Res Commun 2026 Oct 8 PMID 42648174
- The PD Effluentome-A Multi-Omics Atlas Defining the Composition, Transport Dynamics, and Molecular Origin of Peritoneal Dialysis Effluent. — Med Sci (Basel) 2026 Aug 19 PMID 42646630
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Applied Molecular Transport.
Full AMTI Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.